Pancreatic Cancer Research

ResearcherSun Yat-sen University Cancer CenterActive in the last 2 years

Qi Quan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1493-4042; OpenAlex author ID A5112367165. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. Phase II study of SOXIRI (S-1/oxaliplatin/irinotecan) chemotherapy in patients with unresectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2023.12.008↗
  2. Comparison the efficacy and safety of different neoadjuvant regimens for resectable and borderline resectable pancreatic cancer: a systematic review and networ… Co-author DOI 10.1007/s00228-022-03441-9↗
  3. Real World First-Line Treatments and Outcomes of Nab-Paclitaxel Plus Gemcitabine, mFOLFIRINOX and GEMOX in Unresectable Pancreatic Cancer from a Chinese Single… Co-author DOI 10.3390/curroncol28010023↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guifang Guo · 3 shared papers, 2020–2024 · strength 0.51
  2. Xujia Li · 2 shared papers, 2023–2024 · strength 0.39
  3. Shengping Li · 2 shared papers, 2023–2024 · strength 0.39
  4. Feng‐Hua Wang · 2 shared papers, 2020–2024 · strength 0.31
  5. Miao‐Zhen Qiu · 1 shared paper, 2024 · strength 0.20
  6. Yuhong Li · 1 shared paper, 2024 · strength 0.20
  7. Jinsheng Huang · 1 shared paper, 2023 · strength 0.19
  8. Dongsheng Zhang · 1 shared paper, 2020 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.